Science Daily·3 min read·medium
Common antidepressant may ease long COVID’s crushing fatigue
✦AI Summary
A global clinical trial has found that the antidepressant fluvoxamine can help reduce fatigue and improve quality of life for patients suffering from long COVID. The study, involving nearly 400 participants, suggests this existing, inexpensive medication could be a viable treatment option.
A widely available antidepressant may provide meaningful relief for people experiencing persistent fatigue from long COVID, according to a global clinical trial co-led by McMaster University.
healthscience
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in